"Although it has been noted that oral antiviral drugs like Molnupiravir produced by the Merck company and Paxlovid prepared by the Pfizer company of the US reduce the risk of hospitalization among those infected with the COVID-19 virus, the World Health Organization continues its investigations in this regard," said Head of the World Health Organization (WHO) Country Office in Azerbaijan Hande Harmanci to APA.
She said that based on the information we have, we can confirm that even if these drugs are proven safe and effective, they will not be an alternative to vaccines.